Esmolol

Ovarian Cyst

Sodertalje HospitalSmall moleculePhase 1/2Dormant

CCC

52/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 37/ 100
Competitive Position: 95/ 100

Competitive context

2 Active assets in the Ovarian Cyst cohort.

Asset / Sponsor	Phase	Rating
Danazol Centre for Endocrinology and Reproductive Medicine, Italy	Phase 4	BB
Letrozole Wake Forest University Health Sciences	Phase 4	BB
Cetrotide Zagazig University	Phase 4	BB
Ganirelix Assaf-Harofeh Medical Center	Phase 4	BB
ROPIVACAINE San Gerardo Hospital	Phase 3	BB

View all 13 →

Same molecule, other indications

Esmolol is also rated in:

Intraoperative AwarenessDormant

BB

Indicative ·

65 / 100

hemorrhagic strokeDormant

BB

Indicative ·

65 / 100

post-operative pain, non-human animalDormant

B

Indicative ·

62 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.